These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3359114)

  • 21. Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.
    Freedman SB; Beer MS; Harley EA
    Eur J Pharmacol; 1988 Oct; 156(1):133-42. PubMed ID: 3208836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
    J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of halothane on high affinity agonist binding and guanine nucleotide sensitivity of muscarinic acetylcholine receptors from brainstem of rat.
    Dennison RL; Anthony BL; Narayanan TK; Aronstam RS
    Neuropharmacology; 1987 Aug; 26(8):1201-5. PubMed ID: 3116449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C.
    Garcia Ruiz AJ; Zambelli M; La Porta C; Ladinsky H; Consolo S
    Eur J Pharmacol; 1993 Jan; 244(2):125-31. PubMed ID: 8432309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
    Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
    J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit.
    Lepor H; Kuhar MJ
    J Urol; 1984 Aug; 132(2):392-6. PubMed ID: 6737602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
    Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
    Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.
    Linville DG; Hamel E
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):179-86. PubMed ID: 7477441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP.
    Michel AD; Stefanich E; Whiting RL
    Eur J Pharmacol; 1989 Aug; 166(3):459-66. PubMed ID: 2806372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
    Md Anisuzzaman AS; Nishimune A; Yoshiki H; Uwada J; Muramatsu I
    J Pharmacol Exp Ther; 2011 Oct; 339(1):186-93. PubMed ID: 21719469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors.
    Maass A; Mohr K
    Eur J Pharmacol; 1996 Jun; 305(1-3):231-4. PubMed ID: 8813558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ionic strength on cardiac muscarinic receptors.
    Burgen AS
    Br J Pharmacol; 1986 Jun; 88(2):451-5. PubMed ID: 3730701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclassification of atrial and intestinal muscarinic receptors of the rat--direct binding studies with agonists and antagonists.
    Brunner F
    Br J Pharmacol; 1989 Jun; 97(2):572-8. PubMed ID: 2758230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype specificity of the muscarinic receptor-stimulated GTPase response in the rat cortex.
    Ghodsi-Hovsepian S; Messer WS; Hoss W
    Neurosci Lett; 1990 Mar; 110(1-2):148-54. PubMed ID: 2158014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.